The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
CBL-514 is an experimental injectable that is described as inducing adipocyte apoptosis, a programmed cell-death process, in fat cells. The newest evidence is a 2026 MRI analysis showing that people who received CBL-514 had lower visceral adipose tissue (VAT) volume around their abdominal organs at Weeks 4 and 8–12, while people who received placebo had higher volume. That is an early, small, conference-level result. It measures tissue volume, not health outcomes, and it is not evidence that the drug is available for use.
What “kills fat cells” means
Fat cells can get smaller in two quite different ways. They can release stored lipid and remain alive, which is ordinary shrinking. Or they can be removed through apoptosis, the cell’s own controlled self-destruction. The headline’s claim rests on the second mechanism. The developers’ description of CBL-514 uses that term, but the scans reported so far measure tissue volume, not cell counts. A falling volume on MRI is consistent with fat cells dying, but it cannot confirm the mechanism by itself.
Two studies, two kinds of fat
Two separate sets of results are often blended together in coverage of CBL-514. One concerns visceral fat, the metabolically active fat packed around the liver, intestines and other organs. The other concerns subcutaneous fat, the layer under the skin of the abdomen. They use different measurements, different trial designs and different levels of publication.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOutdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware match| Feature | Visceral fat MRI analysis (EASD 2026) | Subcutaneous fat Phase 2 study (2025) |
|---|---|---|
| Publication status | One-page conference abstract, EASD Annual Meeting, Milan, 2026 | Peer-reviewed article, Aesthetic Surgery Journal 45(6):611–620, published 2025-03-04 |
| Fat compartment | Visceral fat, measured as L2–L3 VAT volume | Abdominal subcutaneous fat |
| Participants | 46 evaluable: 26 CBL-514, 20 placebo, drawn from Phase 2 studies CBL-0204 and CBL-0205 | 76 randomized in a 2:1 ratio |
| Treatment schedule | Not stated in the abstract | Up to four treatments at four-week intervals |
| Measurement | MRI with AI-assisted image segmentation | Primary endpoint: proportion losing at least 150 mL of subcutaneous fat volume from baseline |
| Main result | Lower VAT volume with CBL-514 than placebo at Weeks 4 and 8–12 | 69.6% of CBL-514 versus 0% of placebo had at least 150 mL less fat at eight weeks after the final treatment (intention-to-treat, P<.001) |
| Follow-up | Weeks 4 and 8–12 | Four and eight weeks after the final treatment |
| Completion | Not stated in the abstract | 38 of 75 treated participants completed the study |
| Sponsorship | Caliway Biopharmaceuticals is among the listed author affiliations; sponsorship terms not stated | Sponsored by Caliway Biopharmaceuticals, which took part in design, data collection, analysis, interpretation, manuscript writing and the decision to submit |
The visceral fat numbers
The abstract by Yu-Fang Ling and coauthors describes evaluable MRI data from 26 CBL-514 recipients and 20 placebo recipients. Participants had a BMI of 22–30 kg/m² and a weight change of less than 3 kg. Baseline L2–L3 VAT volume averaged 642.5 mL in the CBL-514 group and 677.4 mL in the placebo group, with no significant baseline difference.
#1 Best Overall
- YOUR OWN FITNESS GUIDE - Go anywhere you have to but take along with these easy to carry body fat calipers with you so that you can keep a check on your body fat percentage for a super slim you.
- PULL UP BODY HEALTH - Give a push up to your body health by keeping a check on your body fat with these calipers for body fat made of thermo plastic polymer material for results in no time at all.
- MOTIVATE YOURSELF - To get a BMI measurement tool that gives just right test results, to motivate yourself to work harder, for a no fat slim body that you love, go for the personal body fat tester from Accu Measure.
- GET DONE WITH THE JOB - Want an accurate measurement of your body fat? Start using the Accu Measure body fat caliper with ball and socket that gives a clear cut feel and a clear sound to let you know when to stop the measurement.
- PROFESSIONAL GRADE - Accu Measure brings for you a professional grade body fat caliper with a clear scale that can be used by health care people as well as by you for a quick check up at home.
| Timepoint | CBL-514 mean change | Placebo mean change | Percent change, CBL-514 vs placebo | Between-group difference, t-test | Between-group difference, Hodges–Lehmann |
|---|---|---|---|---|---|
| Week 4 | −65.5 mL | +29.4 mL | −10.9% vs +4.6% | −94.9 mL (p=0.0015) | −73.4 mL (p=0.0009) |
| Week 8–12 | −58.1 mL | +79.4 mL | −7.3% vs +18.4% | −137.5 mL (p=0.0015) | −116 mL (p=0.0020) |
Two kinds of figure appear in this table, and they answer different questions. The within-group change describes what happened in each arm on its own. The between-group difference is the placebo-adjusted comparison, which is the number that supports the claim that CBL-514 outperformed placebo. Science News reports rounded four-week figures of nearly 71 mL lower with CBL-514 and 31 mL higher with placebo. Those rounded values differ from the abstract’s mean changes, so quote the abstract’s exact figures when citing the result.
The authors conclude: “CBL-514 significantly reduced MRI-assessed L2-L3 VAT volume compared with placebo.” They add that the reduction “may offer future metabolic benefits.” That second statement is a hypothesis about what the volume change might mean, not a finding the data demonstrate.
Rank #2
- NEW DESIGN! ACCURATELY DETERMINE BODY FAT PERCENTAGE: Manage your health wisely with the newly designed MEDca Body Fat Caliper with body measurement tape and get very accurate consistant measurements every time. That's because our body fat caliper includes a full set including a click in caliper measure with slide ruler, instructional chart, and body measuring tape which means that you'll be able to measure your body fat content easily and accurately, resulting in more effective dieting!
- SIMPLE! PINCH, CLICK & READ: Now it has never been easier to measure your body fat by yourself and in the comfort of your own home. Our Personal Body Fat Testers feature a ball socket and slide rule so you can quickly and accurately measure your body fat. Simply move the slide rule to the right, pinch your skin fold, squeeze measuring jaws until the ball socket clicks in place and check your results.
- RELIABLE AND EASY TO USE: When it comes to losing weight & building muscle counting fat is what matters and we believe measuring your body fat should be easy. That's why his body fat caliper and body tape measurement tool has easy to read inch and millimeter marks and comes with an instruction card for measuring so that it couldn't be easier. The slide rule lets you know your result without losing its place on the scale.
- DURABLE! BEST QUALITY: This body fat measuring tool and body measuring tape is small, light, discrete, fits in your gym bag and made of durable plastic construction. This caliper gives you the same accurate results as other body fat measurement devices without the high prices costing up to hundreds or more
- TRUSTED BRAND! 100% SATISFACTION GUARANTEE: When entrusting your health into other’s hands, it is natural to worry. Let MEDca handle your body fat measurement device needs. We are happy to serve you in any way we can and are eager to meet all of your needs. If for whatever reason you are not 100% satisfied, we will do everything in our power to make sure that you leave happier and healthier. It's our promise to you!
What the data cannot tell you
- Health outcomes. The abstract reports no diabetes incidence, cardiovascular events, insulin sensitivity or other clinical endpoints. A smaller visceral fat volume is not the same as a lower risk of disease.
- Durability. Follow-up ends at Weeks 8–12. Whether the volume reduction persists, rebounds or reverses after that is unknown.
- Who the result applies to. The analysed group is small and selected: 46 people with BMI 22–30 kg/m² and little weight change. People outside those criteria are not represented.
- Safety. The available safety information comes from the 2025 subcutaneous study, where injection-site reactions were the most common treatment-emergent adverse events and were described as mild to moderate. Groups of this size cannot establish uncommon harms.
- Attrition. Only 38 of 75 treated participants completed the 2025 study. The intention-to-treat analysis includes everyone randomized, but readers should weigh the completion rate alongside that figure.
Evidence gap
The visceral fat analysis has so far appeared only as a one-page conference abstract. Full methods, the complete statistical report, safety data and the reasons for selecting this subset are not part of the public record covered here. Treat the abstract as the only available account of the MRI findings.
Status and access
CBL-514 is investigational. The sources do not establish regulatory authorization, routine clinical availability or a route for patients to obtain it. Science News reports that larger efficacy and safety studies are ongoing. Anyone seeing CBL-514 offered for sale or home use should treat that offer as unverified.
Quick Recap
Best Value
- You will Receive (1) Trimcal 4000 Fat Caliper & (1) Trimcal Body Measure Tape
- Includes Fat % Chart for Men & Women
- Using the Trimcal 4000, you can accurately take the guesswork out of analyzing your body fat %.
- Dual Spring-loaded arm assures reproducible results
- Great for Tracking Muscle, Weight Loss, & Pregnancy Measurements.
Rank #4
- Dual-Sided Readings for Left/Right Hand Use – Accurate Fat & Muscle Tracking
- Includes Trimcal 4000 Caliper / Trimcal Body Meaure Tape / Fat % Chart for Men & Women
- Dual Spring-loaded arm assures reproducible results
- Great for Tracking Muscle, Weight Loss, & Pregnancy Measurements
Rank #3
![Sequoia Fitness TrimCal 4000 Body Fat Caliper (Black) [Health and Beauty] with Fat% Chart](https://m.media-amazon.com/images/I/41b-D6V8jQL._SL160_.jpg)
- Accurate | Affordable | Durable | Easy to Use.
- Dual Spring Calibration
- Low cost Body Fat caliper meets all of the requirements for jaw pressure and accuracy.
- Comes with Male & Female Body % Chart
- Lightweight
Questions to ask about any CBL-514 claim
- Is it a peer-reviewed paper or a conference abstract?
- Does it concern visceral fat, subcutaneous fat, or total body weight?
- Is the number a within-group change or a placebo-adjusted difference?
- How long was follow-up, and does it extend beyond 12 weeks?
- Does it measure tissue volume or a clinical outcome such as disease incidence?
- Who sponsored the work, and what role did the sponsor play?
Sources
- Yu-Fang Ling et al., “CBL-514, a first-in-class adipocyte apoptosis-inducing injection, reduces MRI-measured L2-L3 visceral adipose tissue: translational evidence from preclinical models to a Phase 2 clinical trial,” EASD Annual Meeting, Milan, 2026 (one-page conference abstract).
- Gold et al., “Efficacy and Safety of CBL-514 Injection in Reducing Abdominal Subcutaneous Fat: A Randomized, Single-Blind, Placebo-Controlled Phase II Study,” Aesthetic Surgery Journal 45(6):611–620, published 2025-03-04.
- Tina Hesman Saey, “An experimental drug kills fat cells, rather than shrinking them,” Science News, accessed 2026-10-08.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
